Atlanta Doctor Settles Medical Fraud Case for ₹161 Crore Over Alleged Unnecessary Procedures

Indian-American Urologist Settles $14 Million Healthcare Fraud Case

An Indian-origin urologist and his Atlanta clinic have agreed to pay approximately $14 million (₹161 crore) to settle allegations of extensive healthcare fraud involving multiple federal programs, according to the U.S. Department of Justice.

Dr. Jitendra Patel and Advanced Urology will resolve claims that they systematically billed Medicare, Medicaid, TRICARE, and other federal healthcare programs for procedures that were either medically unnecessary or never performed, the Justice Department announced on April 2.

The settlement addresses violations of the False Claims Act and the Georgia False Medicaid Claims Act, following an extensive investigation involving the FBI and other federal agencies. The case came to light after two whistleblowers filed lawsuits exposing the alleged fraudulent practices.

Former employee Lorraine Perumal-Szramel and former clinic physician Dr. Himanshu Aggarwal independently alleged that Advanced Urology operated with a business model that prioritized profit generation over appropriate patient care. Court documents detail how the clinic allegedly subjected nearly every new patient to a battery of invasive tests without medical justification.

Among the most serious allegations were claims that the clinic routinely implanted sacral nerve stimulators without proper evaluation periods, performed excessive cystoscopies and retrograde pyelograms that deviate from standard urological care protocols, conducted genital electromyography tests with questionable necessity, and ordered ultrasounds beyond medical need.

The whistleblowers also described a pattern of “upcoding” – billing for complex procedures like Direct Visual Internal Urethrotomy when only simpler treatments were actually performed. Local media outlet FOX 5 Atlanta corroborated these allegations, reporting instances where surgeries were billed to federal programs despite never being conducted.

“Billing for medically unnecessary procedures or for services that were never performed constitutes fraud against federal healthcare programs,” said U.S. Attorney Theodore S. Hertzberg in a statement. “This settlement demonstrates our commitment to protecting taxpayer dollars and ensuring the integrity of healthcare programs serving vulnerable populations.”

Georgia Deputy Attorney General Jim Mooney characterized the scheme as theft of taxpayer funds, while FBI officials emphasized that the clinic’s practices placed financial gain above patient welfare – a particular concern in specialized fields like urology where patients often have limited options for care.

The settlement reflects the growing scrutiny of healthcare billing practices across the United States, particularly in specialized medical fields where procedures may be technically complex and difficult for patients to evaluate independently. Federal authorities have intensified efforts to combat healthcare fraud, which costs taxpayers billions annually and potentially compromises patient safety.

While authorities have not definitively established whether patients suffered long-term harm from unnecessary procedures, the investigation highlighted significant ethical breaches in patient care. Medical ethics experts note that unnecessary invasive procedures carry inherent risks of complications, infections, and psychological distress for patients.

The settlement includes provisions for the whistleblowers to share approximately $2.94 million (₹33.8 crore) of the recovery amount – a standard practice under qui tam provisions of the False Claims Act designed to encourage insiders to report fraud.

Healthcare compliance experts emphasize that this case underscores the importance of robust oversight in medical billing practices, particularly in specialty clinics where patients may have limited ability to assess the necessity of recommended procedures.

“This settlement serves as a reminder that healthcare providers must prioritize patient needs over financial incentives,” said a healthcare policy analyst familiar with the case. “The substantial financial penalties reflect the seriousness with which federal authorities view exploitation of public healthcare programs.”

The case against Dr. Patel and Advanced Urology adds to a growing list of similar settlements nationwide, signaling continued federal emphasis on combating healthcare fraud through whistleblower protections and coordinated multi-agency investigations.